Rankings
▼
Calendar
ARGX Q2 2021 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$46B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$420M
+1277.4% YoY
Gross Profit
$189M
45.1% margin
Operating Income
$80M
19.1% margin
Net Income
$53M
12.7% margin
EPS (Diluted)
$0.99
Cash Flow
Operating Cash Flow
-$190M
Free Cash Flow
-$192M
Stock-Based Comp.
$92M
Balance Sheet
Total Assets
$3.2B
Total Liabilities
$261M
Stockholders' Equity
$3.0B
Cash & Equivalents
$1.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$420M
$31M
+1277.4%
Gross Profit
$189M
-$138M
+237.4%
Operating Income
$80M
-$198M
+140.6%
Net Income
$53M
-$202M
+126.4%
Geographic Segments
U
$317M
67%
C
$152M
32%
Countries Other Than United States And China
$1M
0%
← FY 2021
All Quarters
Q4 2021 →